Jan 21, 2016
from 12:00 PM to 01:00 PM
|Where||Brinkhous-Bullitt, Room 219|
|Contact Name||Donna Polat|
|Add event to calendar||
The topic for the Jan. 21st session of the Research Ethics Grand Rounds Spring 2016 series is “Informed Consent for Oncology Phase 1 Clinical Trials in the 21st Century”.
Time: 12:00 p.m.-1:00 p.m.
Location: Room 219, Brinkhous-Bullitt Building, UNC School of Medicine
Drs. Katie Reeder-Hayes and Claire Dees
UNC Division of Oncology, Lineberger Comprehensive Cancer Center
The design of phase 1 clinical trials in oncology has evolved dramatically in the past decade, in terms of the types of drugs used in early experimental trials, the ways in which they are combined, and the points in the disease trajectory at which they are offered. We will review changes in phase 1 trial design, present preliminary findings from a novel study embedding qualitative decision making research in a phase 1 oncology trial, and discuss implications of this evolution for informed consent from the physician and patient perspective.